At this year's BDIA Dental Showcase, attendees discovered the BeVigilant OraFusion System, which provides clinicians with an assessment to aid in the early detection of oral cancer.

Currently, the survival rate for oral cancer is 50%. This is due to delayed detection and late intervention. Detecting cancer in its early stages helps to dramatically increase survival rates to 90%.

figure 1

While dental professionals are diligent in their work, it can be incredibly helpful to have a secondary pre-diagnostic check to produce a report of low, moderate or elevated levels of risk associated with oral cancer.

If you were unable to attend BDIA Dental Showcase, and would like more information about the BeVigilant OraFusion System, visit the website and get in touch with the team today.

For more information, visit https://totaltmj.co.uk/products/bevigilant-orafusion/ or email info@totaltmj.co.uk.